, 4 b s t r w -The active site of porphobilinogen (PBG) deaminase has been enriched with carbon-13 using cells of genetically engineered E . coli. NMR spectroscopy has uncovered the structure of a novel dipyrromethane cofactor, covalently bound through Cys-242, which acts as a nucleophilic site for the covalent binding of substrate. Based on the results of pulse experiments with 13C-enriched S-adenosyl methionine (SAM), the sequence of methylation in the overall conversion of uro'gen 111 to cobyrinic acid is CZ > C7 > CZO > c 1 7 > C12a > C I > Cs > Cis. These results are incorporated into a mechanistic scheme for comn biosynthesis which also takes into account the discovery of a new series of corphinoids based on the type-I porphyrin template.
INTRODUCTION
For the past 20 years our laboratory has been engaged in the fascinating process of discovering how Nature synthesizes the comn structure from 8-aminolevulinic acid (ALA), S A M , and cobalt ion. These two decades of biosynthetic, enzymological and synthetic studies are summarized in Scheme 1 which shows all the known intermediates including PBG, Uro'gen I11 and the three methylated pre-comnoids (in their reduced forms) which were unknown at the outset. Our discussion will focus on two specific topics drawn from both "early" and "late" segments of the pathway. The first topic is concerned with mechanistic and structural proposals for the enzyme PBG deaminase which, together with uro'gen JII synthase, is responsible for the construction of the type I and I11 uro'gens. The second theme encompasses the sequence of methylations leading finally to cobyrinic acid, together with a remarkable new series of corphinoids, which result from methylation of uro'gen I.
THE E N Z Y M E S OF TETRAPYRROLE SYNTHESIS
PBG deaminase (EC4.3.1.8) catalyzes the tetramerization of PBG (I) to preuro'gen (hydroxymethylbilane, HMB; 2)1,2 which is cyclized with rearrangement to the unsymmetrical uro'gen I11 (3 by uro'gen I11 synthase (EC4.2.1.75) (Scheme 1). In the absence of the latter enzyme, preuro'gen a) cyclizes to uro'gen I a ) , 3 which, as discussed below, is a substrate for the methylases of the vitamin B12 pathway.4~5 We have constructed a plasmid pBG 101 containing the Escherichiu coli hemC gene6 for deaminase. E. coli (TBI) transformed with this plasmid produces deaminase at levels greater than 200 times those of the wild strain6 thereby allowing access to substantial quantities of enzyme for detailed study of the catalytic site. Previous work with deaminase (from Rhodopseudomows spheroides) had established that a covalent bond is formed between substrate and enzyme. Application of 3H-NMR spectroscopy to the mono PBG adduct (ES-1) revealed that, in contrast to a claim7 since withdrawn8 that the eNH2 of a lysine residue is covalently attached to substrate, the observed (rather broad) 3H chemical shift indicated bond formation with a cysteine thiol group at the active site. Recently, we have found that a novel cofactor, derived from ALA during the biosynthesis of deaminase, is covalently attached to one of the four cysteine residues of the enzyme in the form of a dipyrromethane which, in turn, becomes the site of attachment of the succeeding four moles of substrate during the catalytic cycle. First it was shown that, at pH < 4, PBG deaminase (5) rapidly developed a chromophore (hmax 485nm) diagnostic of a pyrromethene (as 6), whilst reaction with Ehrlich's reagent generated a chromophore typical of a dipyrromethane (hmax 560nm) changing to 490nm after 5 -I0 min. The latter chromophoric interchange was identical with that of the Ehrlich reaction of the synthetic model pyrromethane (1) and can be ascribed to the isomerization shown (Scheme 2) for the model system (1). Incubation of E. coli strain SASX41B (transformed with plasmid pBG 101, hemA-requiring ALA for growth) with 5-'3C-ALA (100 mg/l.; 90 atom 13C %) afforded highly enriched (> 80% 13C) enzyme for NMR studies. At pH8, the enriched carbons of the dipyrromethane (py-CH2-py) are clearly recognized at 24.0 pprn (py-CHz-py), 26.7 ppm (py-CH2-X), 118.3 ppm (a-free pyrrole) and 129.7 pprn (a-substituted pyrrole) (Fig la) . Comparison with synthetic models reveals that a shift of 26.7 ppm is in the range expected for an a-thiomethyl pyrrole (py-CHz SR). Confirmation of the dipyrromethane (rather than oligo pyrromethane)g came from the l3C INADEQUATE spectrum taken at pH12 (Fig lb) which reveals the expected coupling only between py-CH2-py (6 24.7) and the adjacent substituted pyrrole carbon (6 128.5 ppm). When the enriched deaminase was studied by INVERSE INEPT spectroscopy, each of the protons attached to l3C-nuclei were observed as shown in Fig. lc . The 13C-NMR spectra of the ES complexes showed attachment of PBG at the a-free pyrrole of the enzyme. Next, a specimen of deaminase was covalently inhibited with [2,11-13C2]-2-bromo PBG (8, Fig. 2 ). The CMR spectrum (pH12) is consistent only with structure 9. The site of covalent attachment of substrate (and inhibitor) is therefore 
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the free a-pyrrole carbon at the terminus of the dipyrromethane in the native enzyme, leading to the structural and mechanistic proposal shown in Scheme 3. We suggest that PBG is incorporated into the apoenzyme a folding and that the frst (kinetic) encounter of PBG deaminase with substrate involves attachment of PBG (with loss of NH3) to the a-free pyrrole position of the dipyrromethane to form the ES1 complex (Scheme 3). The process is repeated until the "tetra PBG' (ES4) adduct (19) is formed. At this juncture site-specific cleavage of the hgxapyrr& chain (at -1 ) releases the azafulvene bilane u) which becomes the substrate of uro'gen I11 synthase, or in the absence of the latter enzyme, is stereospecifically hydrated3 to Hh4B (2) at pH12, or is cyclized chemically to uro'gen I (4) at pH S 8. Recent independent and complementary work from two other laboratories*~g has reached similar conclusions regarding the catalytic site but does not address the question of the covalent linkage to the enzyme or the exact chain length of the oligopyrrolic cofactor. The present study defines both the number of PBG units (two) attached to the native enzyme at pH8 as well as revealing the identity of the nucleophilic group (Cys-SH) which anchors the dipyrromethane (and hence the growing oligopymolic chain) to the enzyme.lO Site specific mutagenesis and chemical cleavage has now revealed Cys-242 as the point of attachment of the cofactor.6b
Confirmation of these proposals by 3-dimensional X-ray structural analysis of crystalline deaminase is in progress. 
TEMPORAL RESOLUTION OF THE METHYLATION SEQUENCE IN CORRIN BIOSYNTHESIS
Continuing our account of the fate of the uro'gens in Biz producing bacteria, investigations of the biosynthetic pathway to vitamin BIZ in collaboration with Dr. G. Miiller (Stuttgart) have recently uncovered the sequence of methylations which mediate the conversion of the precursor uro'gen I11 (3) to cobyrinic acid (1) (Scheme 4) using cell-free extracts of Propionibacteriwn shermanii and a series of carefully chosen conditions whereby the SAMderived methyl groups labeled with 13C are "titrated" into the comn structure by pulse experiments.6 The complete methylation sequence12 is shown in Fig. 3 , i.e. CZ > C7 > CZO > c 1 7 > C1za > C i > C5 > ci5 and is confirmed by I H spectroscopy (Fig. 4) The sequence can be correlated with a set of proposed structures6 (Scheme 4) which implicates both pyrrocorphin (F-V) and corphin (F-V1) intermediates. The extracts of incubation mixtures containing '3C-labeled ALA and 13CH3-SAM have provided four novel metabolites whose constitutions have been determined by 13C-NMR spectroscopy on 30 -100 pg samples. The results of these structural investigations415 are shown in Scheme 5 and rely heavily on the application of 13C-INADEQUATE spectroscopy. Factor Si, in common with three further isomers sZ-s4, is a tetramethylated version of uro'gen I. Thus, while not on the direct pathway to BIZ, which requires the unsymmetrical type I11 template as precursor, these new compounds bear evidence of operation of the first three or four methylases of the Biz pathway on the substrate uro'gen I. Indirect evidence for the intervention of the 19-acetyl conin conin sequence comes from examination of the l3C-NMR spectrum of Biz enriched in both 13C (from 13C-4-ALA) and 2H (from Dz0). The primary deuterium isotope effecf of 3.3 for,the introduction of 2H at C-19 strongly suggests the kinetic quenching of the carbanion generated uniquely at t h s position by loss of acetic acid dunng conversion of Factor I X to cobynnic acid.13 Using the genetic maps for Biz synthesis now becoming available it should be possible to determine the structures of the remaining unknown intermediates through the construction of mutants blocked at the appropriate points and we can look forward to rapid progress in this area, as well as in the enzymology of the separated methylase activities where as many as 7 different enzymes may be involved (CZ/c7, CZO, c17, Ciz, Ci, C5, cl5).
